Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P P Mager

Showing results (91-100 of 104) with videos related to

Pageof 11
Sort By:
Gegenbaurs Morphologisches Jahrbuch|January 1, 1974
[The probability network. I. Testing for normal distribution and analysis of a mixed group]P P Mager, R Mager
Die Pharmazie|August 1, 1982
Quantitative structure-activity relationships of reactivators of phosphylated acetylcholinesterase. Part 2P P Mager, S Das Gupta
Die Pharmazie|November 1, 1982
Organotins: toxicity and oligomycin-like effect on mitochondria in dependence on chemical structureP P Mager, S Das Gupta
Die Pharmazie|August 1, 1983
A free-wilson study of 4-piperazinyl-10h-thienobenzodiazepine analoguesH G Schauzu, P P Mager
Die Pharmazie|May 1, 1981
Structure-toxicity relationships applied to grayanotoxinsP P Mager, A Seese, K Takeya
Drug Design and Discovery|June 1, 1993
QSAR and molecular modelling of antimuscarinic 7-amino-1-hydroxy-5-heptyn-2-onesP P Mager, H Mager, H Walther
Carbohydrate Research|September 23, 1996
Investigation of the conformational behaviour of permethylated cyclodextrins by molecular modellingR Reinhardt, M Richter, P P Mager
Die Pharmazie|January 1, 1979
[On the use of the relative surface tension xi in studies on the structure-activity relationships (author's transl)]P P Mager, M Paintz, U Wenzel
Die Pharmazie|December 1, 1982
Judging models in QSAR- and LFE-like studies if there are no replications: correlation of dipeptidyl peptidase IV hydrolytic activities of L-Alanyl-L-alanine phenylamidesH Mager, B Schneeweiss, A Barth, et al.
Die Pharmazie|December 1, 1980
[Growth inhibition in Chlorella vulgaris by 4-substituted 3-methyl-1-phenylpyrazolin-5-one derivatives as related to their chemical structure]P P Mager, H Böhm, H Wilde, et al.
Pageof 11

Showing results (91-100 of 104) with videos related to

Sort By:
Pageof 11
Gegenbaurs Morphologisches Jahrbuch|January 1, 1974
[The probability network. I. Testing for normal distribution and analysis of a mixed group]P P Mager, R Mager
Die Pharmazie|August 1, 1982
Quantitative structure-activity relationships of reactivators of phosphylated acetylcholinesterase. Part 2P P Mager, S Das Gupta
Die Pharmazie|November 1, 1982
Organotins: toxicity and oligomycin-like effect on mitochondria in dependence on chemical structureP P Mager, S Das Gupta
Die Pharmazie|August 1, 1983
A free-wilson study of 4-piperazinyl-10h-thienobenzodiazepine analoguesH G Schauzu, P P Mager
Die Pharmazie|May 1, 1981
Structure-toxicity relationships applied to grayanotoxinsP P Mager, A Seese, K Takeya
Drug Design and Discovery|June 1, 1993
QSAR and molecular modelling of antimuscarinic 7-amino-1-hydroxy-5-heptyn-2-onesP P Mager, H Mager, H Walther
Carbohydrate Research|September 23, 1996
Investigation of the conformational behaviour of permethylated cyclodextrins by molecular modellingR Reinhardt, M Richter, P P Mager
Die Pharmazie|January 1, 1979
[On the use of the relative surface tension xi in studies on the structure-activity relationships (author's transl)]P P Mager, M Paintz, U Wenzel
Die Pharmazie|December 1, 1982
Judging models in QSAR- and LFE-like studies if there are no replications: correlation of dipeptidyl peptidase IV hydrolytic activities of L-Alanyl-L-alanine phenylamidesH Mager, B Schneeweiss, A Barth, et al.
Die Pharmazie|December 1, 1980
[Growth inhibition in Chlorella vulgaris by 4-substituted 3-methyl-1-phenylpyrazolin-5-one derivatives as related to their chemical structure]P P Mager, H Böhm, H Wilde, et al.
Pageof 11